mitomycin has been researched along with 2,6-dichloroindophenol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akman, SA; Forrest, GL; Hipsher, C; Johnson, R; Pan, SS | 1 |
| Powis, G; Schlager, JJ | 1 |
2 other study(ies) available for mitomycin and 2,6-dichloroindophenol
| Article | Year |
|---|---|
The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
Topics: 2,6-Dichloroindophenol; Carbon Radioisotopes; Cell Extracts; Cell Size; Cell Survival; Colonic Neoplasms; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Intracellular Fluid; Microsomes; Mitomycin; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Porfiromycin; RNA, Messenger; Tissue Distribution; Transcription, Genetic; Tumor Cells, Cultured; Vitamin K | 1992 |
Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.
Topics: 2,6-Dichloroindophenol; Alkylation; Chromatography, High Pressure Liquid; Humans; Kidney; Mitomycin; Mitomycins; NAD(P)H Dehydrogenase (Quinone); Quinone Reductases | 1988 |